69
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Vaccination Shortens the Negative Nucleic Acid Conversion Time of the Older Population: A Retrospective Cohort Study of 73,456 Asymptomatic and Mild Patients with COVID-19 in Shanghai

, , , , , , & show all
Pages 763-773 | Received 23 Nov 2023, Accepted 20 Feb 2024, Published online: 04 Mar 2024

References

  • Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157–160. doi:10.23750/abm.v91i1.9397
  • Murakami N, Hayden R, Hills T, et al. Therapeutic advances in COVID-19. Nat Rev Nephrol. 2023;19(1):38–52. doi:10.1038/s41581-022-00642-4
  • Kirsebom FCM, Andrews N, Stowe J, et al. COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England. Lancet Infect Dis. 2022;22(7):931–933. doi:10.1016/S1473-3099(22)00309-7
  • Information Office of Shanghai Municipality. Shanghai reports on the prevention and control of COVID-19; 2022. https://www.shio.gov.cn/TrueCMS/shxwbgs/2022n_6y/2022n_6y.html. Accessed April 06, 2022.
  • World Helath Organization. Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases: Interim Guidance; 2020.
  • Biohazards/Standards CO. Interim guidelines for collection, processing and transport of clinical specimens from patients under investigation for Middle East Respiratory Syndrome (MERS). Contain Bio Stand. 2024; 24:1.
  • Lee SW. Regression analysis for continuous independent variables in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2022;2:e3. doi:10.54724/lc.2022.e3
  • Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399(10340):2011–2012. doi:10.1016/S0140-6736(22)00838-8
  • Li J, Yuan P, Heffernan J, et al. Fangcang shelter hospitals during the COVID-19 epidemic, Wuhan, China. Bull World Health Organ. 2020;98(12):830–841D. doi:10.2471/BLT.20.258152
  • Bhattacharyya RP, Hanage WP. Challenges in inferring intrinsic severity of the SARS-CoV-2 omicron variant. N Engl J Med. 2022;386(7):e14. doi:10.1056/NEJMp2119682
  • Bhimraj A. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health (US); 2021.
  • Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. doi:10.1001/jama.2020.3786
  • Tsang NNY, So HC, Ng KY, Cowling BJ, Leung GM, Dkm I. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(9):1233–1245. doi:10.1016/S1473-3099(21)00146-8
  • Wang X, Tan L, Wang X, et al. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis. 2020;94:107–109. doi:10.1016/j.ijid.2020.04.023
  • Mohammadi A, Esmaeilzadeh E, Li Y, Bosch RJ, Li JZ. SARS-CoV-2 detection in different respiratory sites: a systematic review and meta-analysis. EBioMedicine. 2020;59:102903. doi:10.1016/j.ebiom.2020.102903
  • Tom MR, Mina MJ. To Interpret the SARS-CoV-2 test, consider the cycle threshold Value. Clin Infect Dis. 2020;71(16):2252–2254. doi:10.1093/cid/ciaa619
  • Rao SN, Manissero D, Steele VR, Pareja J. A systematic review of the clinical utility of cycle threshold Values in the context of COVID-19. Infect Dis Ther. 2020;9(3):573–586. doi:10.1007/s40121-020-00324-3
  • Badua CLDC, Baldo KAT, Medina PMB. Genomic and proteomic mutation landscapes of SARS-CoV-2. J Med Virol. 2021;93(3):1702–1721. doi:10.1002/jmv.26548
  • Okita Y, Morita T, Kumanogoh A. Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis. Inflamm Regen. 2022;42(1):16. doi:10.1186/s41232-022-00205-x
  • Sakano T, Urashima M, Takao H, Takeshita K, Kobashi H, Fujiwara T. Differential kinetics of cycle threshold values during admission by symptoms among patients with mild COVID-19: a prospective cohort study. Int J Environ Res Public Health. 2021;18(15):8181. doi:10.3390/ijerph18158181
  • Le Bert N, Clapham HE, Tan AT, et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J Exp Med. 2021;218(5):doi:10.1084/jem.20202617
  • Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618–1624. doi:10.1016/S0140-6736(22)00327-0
  • Andrews N, Stowe J, Kirsebom F, et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 2022;386(16):1532–1546. doi:10.1056/NEJMoa2119451
  • Cheung P-H-H, Chan C-P, Jin D-Y. Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect. 2022;11(1):1072–1078. doi:10.1080/22221751.2022.2060137
  • Smith DJ, Hakim AJ, Leung GM, et al. COVID-19 mortality and vaccine coverage - hong kong special administrative region, China. MMWR Morb Mortal Wkly Rep. 2022;71(15):545–548. doi:10.15585/mmwr.mm7115e1
  • Tegally H, Moir M, Everatt J, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022;28(9):1785–1790. doi:10.1038/s41591-022-01911-2
  • Tu W, Zhang P, Roberts A, et al. SARS-CoV-2 Infection, hospitalization, and death in vaccinated and infected individuals by age groups in Indiana, 2021‒2022. Am J Public Health. 2023;113(1):96–104. doi:10.2105/AJPH.2022.307112
  • Ceban F, Kulzhabayeva D, Rodrigues NB, et al. COVID-19 vaccination for the prevention and treatment of long COVID: a systematic review and meta-analysis. Brain Behav Immun. 2023;111:211–229. doi:10.1016/j.bbi.2023.03.022